Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Humabs BioMed S.A.
DescriptionAntibody targeting antigenic site III of rabies virus (RABV) glycoprotein
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRabies
Indication DetailsTreat rabies infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today